ARTICLE | Company News
Geron, PanCel Inc. deal
March 10, 2003 8:00 AM UTC
GERN granted a non-exclusive license for its human telomerase reverse transcriptase (hTERT) technology to cellular therapy company PanCel. PanCel will use the technology to develop treatments for Typ...